Tag: Moderna
Moderna: Moderna to meet COVID-19 vaccine sales targets in 2023
(Reuters) – Moderna reported preliminary results on Monday for annual sales of its COVID-19 vaccine above the lower end of its own forecast, at $6.7 billion (6.12 billion euros). ,…
Moderna strengthens its position in the American Covid-19 market – 01/08/2024 at 2:26 p.m.
(AOF) – Moderna reported on Monday preliminary sales in 2023 of $6.7 billion for its Covid-19 vaccine, above the lower limit of its forecasts for the whole year. In November,…
Moderna: The director optimistic for 2024, the title soars
Read also (CercleFinance.com) – In a letter addressed to shareholders, Stéphane Bancel, the director of Moderna, believes that the most optimistic five-year scenario established in 2018 is being realized. “As…
Moderna: the director optimistic for 2024, the title soars
(CercleFinance.com) – In a letter addressed to shareholders, Stéphane Bancel, the director of Moderna, believes that the most optimistic five-year scenario established in 2018 is being realized. “As we reflect…
Wall Street cautious after rally: doubts about interest rates are slowing the start of the new year
Wall Street cautious after rally Doubts about interest rates are slowing the start of the new year January 2, 2024, 11:03 p.m Listen to article This audio version was artificially…
Buying spree worries analysts: Dow sets new record – alarm bells are ringing
Buying spree worries analysts Dow sets new record – alarm bells are ringing December 14, 2023, 11:06 p.m Listen to article This audio version was artificially generated. More info |…
Merck and Moderna: new trial of Keytruda against lung cancer – 11/12/2023 at 2:50 p.m.
(AOF) – Merck and Moderna announce the launch of INTerpath-002, a phase 3 study evaluating V940 (mRNA-4157) in combination with Keytruda (pembrolizumab), Merck’s lead product, for the adjuvant treatment of…
Merck and co inc: Start of phase III clinical trial with Moderna
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Moderna massacred on Wall Street, after its “covid warning”
By Jean-Noël Legalland Published on 02/11/2023 at 2:45 p.m. Photo credit © Reuters (Boursier.com) — Moderna drops 7%…
Moderna lowers its annual turnover forecast as demand for anti-COVID-19 vaccines declines
Published on 02/11/2023 at 2:53 p.m. Photo credit © Reuters (Reuters) – Moderna said on Thursday it…
Moderna: price target sharply lowered at Oddo BHF
(CercleFinance.com) – Oddo BHF reaffirms its ‘outperform’ opinion on Moderna, but with a price target reduced from 205 to 118 dollars, due to an update of its model in order…
Moderna down sharply after deterioration of its post-Covid-19 outlook
(AOF) – Moderna is in sharp decline after lowering its annual outlook. Victim of the lull on the Covid-19 front, the pharmaceutical laboratory (-8.32% to $69.86) is only expecting sales…